Molecular classification and biomarkers of outcome with immunotherapy in extensive-stage small-cell lung cancer: analyses of the CASPIAN phase 3 study.

Autor: Xie, Mingchao1 (AUTHOR), Vuko, Miljenka2 (AUTHOR), Rodriguez-Canales, Jaime3 (AUTHOR), Zimmermann, Johannes2 (AUTHOR), Schick, Markus2 (AUTHOR), O'Brien, Cathy4 (AUTHOR), Paz-Ares, Luis5 (AUTHOR), Goldman, Jonathan W.6 (AUTHOR), Garassino, Marina Chiara7,8 (AUTHOR), Gay, Carl M.9 (AUTHOR), Heymach, John V.9 (AUTHOR), Jiang, Haiyi10 (AUTHOR), Barrett, J. Carl11 (AUTHOR), Stewart, Ross A.12 (AUTHOR), Lai, Zhongwu1 (AUTHOR), Byers, Lauren A.9 (AUTHOR), Rudin, Charles M.13 (AUTHOR), Shrestha, Yashaswi3 (AUTHOR) yashaswi.shrestha@astrazeneca.com
Zdroj: Molecular Cancer. 5/30/2024, Vol. 23, p1-17. 17p.
Databáze: Academic Search Ultimate
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje